TPG, CPPIB team up for $5.2bn pharma buyout

The take-private of IMS Health, comprising $4bn in equity and $1.2bn in debt, is the biggest buyout proposed this year.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this